Passive investing in index funds can generate returns that roughly match the overall market. But investors can ...

IDEXX Laboratories (NASDAQ: IDXX) has outperformed the market over the past 10 years by 11.91% on an annualized basis producing an average annual return of 25.31%. Currently, IDEXX Laboratories has a ...

Ratings for IDEXX Laboratories (NASDAQ:IDXX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview ...

The latest price target for IDEXX Laboratories (NASDAQ:IDXX) was reported by Barclays on December 9, 2025. The analyst firm set a price target for $850.00 expecting IDXX to rise to within 12 months (a ...

Here is how Idexx Laboratories (IDXX) and Artivion (AORT) have performed compared to their sector so far this year.

While they might not represent the most exciting field in the biotech space, animal healthcare companies have been a steady, consistent source of growth in what's often a turbulent market. One company ...

IDEXX Laboratories, Inc. is a U.S. healthcare company, that currently leads the veterinary industry developing diagnostics tools to satisfy veterinarians’ everyday needs. IDEXX has delivered solid and ...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company ...

Pet healthcare is a large and growing global market. Veterinarians are rapidly adopting in-office diagnostic testing tools. Increased testing is the foundation of Idexx's attractive recurring-revenue ...

The stock price of IDEXX Laboratories (NASDAQ: IDXX), an animal healthcare company, has seen a rise of 12% in the last twenty-one trading days, while it is up a large 90% over the last one year. This ...